Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4501)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2022 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Martin-Grau M, Marrachelli VG, Monleon D. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn? World J Hepatol 2022; 14(2): 304-318 [PMID: 35317178 DOI: 10.4254/wjh.v14.i2.304] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i2/304.htm |
| Number | Citing Articles |
| 1 |
Sergio Carracedo, Lisa Lirussi, Lene Alsøe, Filip Segers, Changliang Wang, Zdenka Bartosova, Pavol Bohov, Nuriye B. Tekin, Xiang Yi Kong, Q. Ying Esbensen, Liang Chen, Anna Wennerström, Penelope Kroustallaki, Deborah Ceolotto, Anke Tönjes, Rolf Kristian Berge, Per Bruheim, Garry Wong, Yvonne Böttcher, Bente Halvorsen, Hilde Nilsen. SMUG1 regulates fat homeostasis leading to a fatty liver phenotype in mice. DNA Repair 2022; 120: 103410 doi: 10.1016/j.dnarep.2022.103410
|
| 2 |
Shotaro Kamata, Isao Ishii. Difference Gel Electrophoresis. Methods in Molecular Biology 2023; 2596: 217 doi: 10.1007/978-1-0716-2831-7_16
|
| 3 |
P. Brissot, C. Buffet. Rapport 23-02. Le foie stéatosique non alcoolique : un défi de santé publique. Bulletin de l'Académie Nationale de Médecine 2023; 207(5): 521 doi: 10.1016/j.banm.2023.03.014
|
| 4 |
Baron J. Bechtold, Katherine D. Lynch, Victoria O. Oyanna, M. Ridge Call, Laura A. White, Tyler N. Graf, Nicholas H. Oberlies, John D. Clarke. Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice. Drug Metabolism and Disposition 2024; 52(5): 355 doi: 10.1124/dmd.123.001607
|